Nanjing Molecular Research, Inc.

Calculating rank

USPTO Granted Patents = 2

Forward Citations = 33

Loading Chart...

5 inventors (with patents filed for the assignee):

Junbiao Chang (2 out of 14 patents)

Zheng Wang (2 out of 2 patents)

Qiang Huang (1 out of 15 patents)

4. Runcong Liu (1 out of 1 patent)

5. Suping Zhou (1 out of 1 patent)

2 patents: Sort by Forward Citations

1. 9156874 - Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs (2015-10-13),

2. 9095599 - O-(substituted benzyl) phosphoramidate compounds and therapeutic use (2015-08-04),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

2 Patents

#158 in

#11,649 in China

CN

Nanjing Molecular Research, Inc.

Forward Citations = 33

5 inventors:

Junbiao Chang (2 out of 14 patents)

Zheng Wang (2 out of 2 patents)

Qiang Huang (1 out of 15 patents)

4. Runcong Liu (1 out of 1 patent)

5. Suping Zhou (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nanjing Molecular Research, Inc.. Retrieved from https://idiyas.com/company/nanjing-molecular-research

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]